Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
  • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
  • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
  • A61P11/06—Antiasthmatics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/04—Centrally acting analgesics, e.g. opioids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/06—Antimigraine agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/12—Antihypertensives
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
  • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
  • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
  • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
  • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
  • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
  • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
  • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
  • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
  • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
  • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Animal Behavior & Ethology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Pharmacology & Pharmacy (AREA)
• Engineering & Computer Science (AREA)
• Pulmonology (AREA)
• Pain & Pain Management (AREA)
• Heart & Thoracic Surgery (AREA)
• Cardiology (AREA)
• Neurosurgery (AREA)
• Neurology (AREA)
• Biomedical Technology (AREA)
• Rheumatology (AREA)
• Vascular Medicine (AREA)
• Urology & Nephrology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
• Plural Heterocyclic Compounds (AREA)
• Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Applications Claiming Priority (3)

Publications (2)

Family

ID=27370159

Family Applications (1)

Country Status (34)

Families Citing this family (110)

Family Cites Families (5)

• 1993
  • 1993-06-25 CA CA002099233A patent/CA2099233A1/en not_active Abandoned
  • 1993-06-25 IL IL106142A patent/IL106142A/xx not_active IP Right Cessation
  • 1993-06-28 HR HR931003 patent/HRP931003B1/xx not_active IP Right Cessation
  • 1993-06-28 MX MX9303888A patent/MX9303888A/es unknown
  • 1993-06-28 ZA ZA934624A patent/ZA934624B/xx unknown
  • 1993-06-28 MY MYPI93001250A patent/MY108836A/en unknown
  • 1993-06-29 CN CN93109517A patent/CN1049431C/zh not_active Expired - Lifetime
  • 1993-06-29 JP JP5212045A patent/JP2634372B2/ja not_active Expired - Lifetime
  • 1993-06-29 EP EP93305086A patent/EP0577394B1/en not_active Expired - Lifetime
  • 1993-06-29 DE DE69326977T patent/DE69326977T2/de not_active Expired - Lifetime
  • 1993-06-29 YU YU45293A patent/YU49036B/sh unknown
  • 1993-06-29 DZ DZ930080A patent/DZ1700A1/fr active
  • 1993-06-29 HU HU9403804A patent/HU219713B/hu unknown
  • 1993-06-29 AU AU46561/93A patent/AU4656193A/en not_active Abandoned
  • 1993-06-29 NZ NZ254476A patent/NZ254476A/en not_active IP Right Cessation
  • 1993-06-29 SK SK1600-94A patent/SK281093B6/sk not_active IP Right Cessation
  • 1993-06-29 DK DK93305086T patent/DK0577394T3/da active
  • 1993-06-29 RO RO94-02095A patent/RO114448B1/ro unknown
  • 1993-06-29 ES ES93305086T patent/ES2141133T3/es not_active Expired - Lifetime
  • 1993-06-29 WO PCT/US1993/006181 patent/WO1994000440A1/en active IP Right Grant
  • 1993-06-29 SI SI9300346A patent/SI9300346B/sl unknown
  • 1993-06-29 RU RU94046364A patent/RU2140914C1/ru active
  • 1993-06-29 CZ CZ19943330A patent/CZ288530B6/cs not_active IP Right Cessation
  • 1993-06-29 KR KR1019940704776A patent/KR100301212B1/ko not_active IP Right Cessation
  • 1993-06-29 AT AT93305086T patent/ATE186532T1/de active
  • 1993-08-17 TW TW082106583A patent/TW358808B/zh not_active IP Right Cessation
• 1994
  • 1994-12-19 BG BG99274A patent/BG62963B1/bg unknown
  • 1994-12-28 NO NO945064A patent/NO305698B1/no not_active IP Right Cessation
  • 1994-12-28 FI FI946133A patent/FI111363B/fi not_active IP Right Cessation
• 1997
  • 1997-04-30 BR BR1100375-8A patent/BR1100375A/pt active IP Right Grant
• 1998
  • 1998-08-12 HK HK98109867A patent/HK1009268A1/xx not_active IP Right Cessation
• 1999
  • 1999-11-11 GR GR990402842T patent/GR3031824T3/el unknown
• 2000
  • 2000-09-07 LV LVP-00-118A patent/LV12568B/lv unknown
  • 2000-11-02 CY CY0000052A patent/CY2200B1/xx unknown

Also Published As

Similar Documents